TRIOCHEM PRODUCTS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.4 INR | -.--% |
|
-.--% | -.--% |
1 week
17.40
17.40
1 month
17.4017.40
3 years
17.4017.40
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 87 | 30/75/30 | |
Puran J. Parmar
DFI | Director of Finance/CFO | - | 30/15/30 |
Ureca Deolekar
CMP | Compliance Officer | - | 14/19/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 28/85/28 | |
| Director/Board Member | - | 17/96/17 | |
| Chief Executive Officer | 87 | 30/75/30 |
Triochem Products Limited is an India-based company, which is engaged primarily in the business of manufacturing and exporting of pharmaceuticals products, active pharmaceutical ingredients (APIs) and chemicals. The Company operates through a single segment, which is chemical and pharmaceutical. The Company is an exporter of pharmaceuticals bulk drugs and organic and inorganic chemicals. Its product range includes iodine compounds, citrates and piperazine salts. Its main markets include Europe (Germany, France, Netherlands, United Kingdom), America (United States, Brazil, Mexico, Guatemala) and Southeast Asia (Korea, Indonesia, Taiwan, Australia).
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B |
- Stock Market
- Equities
- TRIPR6 Stock
